Taifo Mahmud „Old drugs, new hope: Biosynthetic engineering of new rifamycin and pactamycin analogues“

HIPS Talk

  • Überblick

    Summary

    Natural products continue to play an important role in drug discovery. About two-thirds of recently approved pharmaceuticals are natural product-derived or nature-inspired chemical entities. Despite their importance in medicine, the number of new bioactive natural products identified in recent years has significantly declined. This trend, coupled with the increased threat of multidrug-resistant infectious agents and cancers, calls for new ways of discovering natural product-based medicines. Through a combination of cutting-edge genetic, biosynthetic, and organic synthetic approaches, we have generated many novel analogues of complex natural products. In this presentation, I will discuss our recent progress in creating analogues of two biologically important natural products, the anti-tubercular drug rifamycin and the anti-cancer antibiotic pactamycin.

     

    CV

    Dr. Taifo Mahmud received a Ph.D. degree in Pharmaceutical Sciences (Natural Products Chemistry) from Osaka University, under direction of Professor Motomasa Kobayashi in 1997. Subsequently, he received a three-year postdoctoral training from Professor Heinz G. Floss at the University of Washington in Seattle, where he was then promoted to the rank of Research Assistant Professor in Chemistry. In 2003, he joined the Oregon State University College of Pharmacy as an Assistant Professor of Medicinal Chemistry. In 2007, he was promoted to Associate Professor, and in 2013, was promoted to full Professor. Dr. Mahmud’s research interests are in bioorganic chemistry and natural product-based drug discovery and development. His group employs a multidisciplinary approach that utilizes cutting-edge technologies in molecular genetics, enzymology, and chemistry to access, study, utilize, and manipulate genes and enzymes, involved in natural product biosynthesis, to produce novel pharmaceuticals, such as antibiotics, anti-malarial, and anti-cancer drugs.


    Datum: 30.09.2013, 17:00

    Veranstaltungsort

    Universität des Saarlandes

    Gebäude und Raum

    Raum 02 in Gebäude B2.1

    Referent

    Taifo Mahmud,
    Oregon State University/USA

    Gastgeber

    Rolf Müller

  • Anfahrt

    So erreichen Sie uns in Saarbrücken

    Das HIPS-Gebäude befindet sich am Osteingang des Saarbrücker Campuses der Universität des Saarlandes. Der Campus liegt vor den Toren der Innenstadt in einem Waldgebiet. Saarbrücken ist die Hauptstadt des Saarlandes, welches im Südwesten Deutschlands liegt und gemeinsame Grenzen mit Frankreich und Luxemburg besitzt.

    Adresse

    Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS)
    Universitätscampus E8 1
    66123 Saarbrücken

    Mit dem Auto

    • von Norden (Köln/Trier) über die Autobahnen A1/A8 zum Autobahnkreuz Neunkirchen, dort A6 in Richtung Saarbrücken
    • von Osten (Kaiserslautern) über die A6
    • von Nord-Westen (Luxemburg) über die A620, vorbei am Stadtzentrum auf die A6 in Richtung Mannheim
    • von Westen (Paris/Metz) und Süden (Strasbourg) über die A6/E50 in Richtung Mannheim

    Ausfahrt Nr. 6, "St. Ingbert-West/Universität" der Beschilderung "Universität Ost" folgen (ca. 6 km)

    Mit dem Zug

    • ICE/TGV- und Intercity-Bahnhof Saarbrücken Hbf
    • man kann den Campus mit Öffentlichen Verkehrsmitteln vom Hauptbahnhof (Linien 112, 124) und aus dem Stadtzentrum (Linien 101, 102, 109, 111) innerhalb von ca. 15 min. erreichen

    Downloads

Kontakt

  • Birgitta Lelarge

    Birgitta Lelarge

    Assistentin der Geschäftsführung

    0681 98806-3022

    0681 98806-3003

    Kontakt